RxDoctor Payments Data

Wayne Hofstetter, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TXNPI 1790874360

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Merck at 40.0% of the total. Reporting peaked in 2019 at $20,248 and has fallen 84.7% since, to $3,095 in 2025.

$42,906in general payments, 2019–2025

Across 43 payments — averaging $997.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$17K
  • Johnson & Johnson$8K
  • Medical Device Business Services, Inc.$8K
  • Intuitive Surgical$5K
  • AstraZeneca$4K
  • Abiomed$149
  • plus $114 from 2 others
$425,927in research payments, 2019–2025

Across 9 payments — averaging $47,325 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ethicon Endo-surgery Inc.$366K
  • Johnson & Johnson$60K

What the payments were for

  • Consulting fees$17,75741%
  • Speaking & faculty fees$7,32017%
  • Travel & lodging$11,74227%
  • Food & beverage$1,4623%
  • Education$4,62611%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck5$17,146
Johnson & Johnson(2 entities)12$8,281
Medical Device Business Services, Inc.7$7,979
Intuitive Surgical11$5,028
AstraZeneca5$4,210
Abiomed1$149
Atricure, Inc.1$97
Davol Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,906 in reported general payments places this provider in the 85th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas

Medicare billing

Part B allowed, 2024
$78,313
Medicare patients
75
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →